Abstract
The discovery of a cardiac production of Chromogranin A (CgA) opened a rich field of research whose result was a cardiovascular dimension of this multifunctional protein and the fragments derived by its proteolytic cleavage. In line with its precursor function, at the cardiac level, CgA undergoes proteolytic processing. Moreover, as shown by ex vivo functional studies, it acts on the heart itself. Through the amino terminal (vasostatin: VS) and catestatin (CST) domains, CgA elicits a direct cardiodepressive, antiadrenergic and cardioprotective influence, acting as a cardiac stabilizer under normal conditions and in the presence of stress (i.e. catecholaminergic, and endothelinergic). At the same time, through the C-terminal Serpinin (Serp), CgA elicits a cardiostimulatory beta-adrenergic-like action. In this chapter, the results of more than 10 years of research will be described in order to illustrate the cardiovascular profile of these peptides, as well as their mechanisms of action. The purpose is to highlight the expanding role this protein and its fragments in the neuroendocrine circuits that finely control heart performance in health and disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Adenylate Cyclase
- Akt:
-
Protein Kinase B
- Au:
-
Aurum
- CA:
-
Catecholamine
- CaM:
-
Calmodulin
- cAMP:
-
Cyclic Adenosine Monophosphate
- CgA:
-
Chromogranin A
- cGMP:
-
Cyclic Guanosine Monophosphate
- Chr:
-
Chromofungin
- CO:
-
Cardiac Output
- CP:
-
Coronary Pressure
- CST:
-
Catestatin
- ECM:
-
Myocardial Extracellular Matrix
- EE:
-
Endocardial endothelium
- ELISA:
-
Enzyme-Linked Immuno Assay
- eNOS:
-
Endothelial Nitric Oxide Synthase
- ERK1/2:
-
Extracellular Signal–regulated Kinase 1/2
- ET-1:
-
Endothelin 1
- GC:
-
Guanylate Cyclase
- GPCR:
-
G protein-coupled receptor
- GSK3β:
-
Glycogen Synthase Kinase 3 beta
- HF:
-
Heart Failure
- HPLC:
-
High-performance liquid chromatography
- HR:
-
Heart rate
- hr:
-
human recombinant
- Hsp90:
-
Heat Shock Protein 90
- HTR:
-
Half Time Relaxation
- I/R:
-
Ischemia/Reperfusion
- IGF-1:
-
insulin-like growth factor-1
- iPLA2:
-
Calcium Independent Phospholipase A2
- IS:
-
Infarct Size
- ISO:
-
Isoproterenol
- LDH:
-
Lactate Dehydrogenase
- L-NAME:
-
Nω-Nitro-L-arginine methyl ester hydrochloride
- LVP:
-
Left Ventricular Pressure
- miRNA:
-
microRNA
- mitoKATP Channel:
-
ATP-Sensitive Potassium Channel
- nAChR:
-
Nicotinic Receptor
- NO:
-
Nitric Oxide
- ODQ:
-
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
- PDE2:
-
Phosphodiesterases type 2
- pGlu-Serp:
-
pyroglutaminated-Serpinin
- PI3K:
-
Phosphatidylinositide 3-Kinase
- PKA:
-
Protein Kinase A
- PKG:
-
Protein Kinase G
- PLN:
-
Phospholamban
- PTIO:
-
2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide
- PTX:
-
Pertussis Toxin
- RISK:
-
Reperfusion Injury Signalling Kinase
- ROS:
-
Radical Oxygen Species
- RPP:
-
Rate Pressure Product
- RyR:
-
Ryanodine receptor
- Serp:
-
Serpinin
- SHR:
-
Spontaneously Hypertensive Rats
- SR:
-
Sarcoplasmic Reticulum
- VE:
-
Vascular Endothelium
- VS:
-
Vasostatin
- WKY:
-
Wistar Kyoto
- WT:
-
Wild-Type
- β-ARs:
-
β-adrenergic receptors
References
Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G (1993) Vasostatins, comprising the N-terminal domains of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5:105–112
Abi-Gerges N, Fischmeister R, Meiry PF (2001) G protein-mediated inhibitoryeffect of a nitric oxide donor on the L-type Ca2+ current in rat ventricularmyocytes. J Physiol 531:117–130
Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC (2008) The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 149(10):4780–4793
Angelone T, Quintieri AM, Pasqua T, Gentile S, Tota B, Mahata SK, Cerra MC (2012) Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Physiol Heart Circ Physiol 302(2):H431–H442
Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC (2015) The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide 50:10–19
Bartizal K, Abruzzo G, Trainor C, Krupa D, Nollstadt K, Schmatz D, Schwartz R, Hammond M, Balkovec J, Vanmiddlesworth F (1992) In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob Agents Chemother 36(8):1648–1657
Bassino E, Fornero S, Gallo MP, Ramella R, Mahata SK, Tota B, Levi R, Alloatti G (2011) A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium. Cardiovasc Res 91(4):617–624
Bayraktutan U, Yang ZK, Shah AM (1998) Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res 3:719–726
Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH (1995) The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27:383–396
Brekke JF, Osol GJ, Helle KB (2002) N-terminal chromogranin-derived peptides as dilators of bovine coronary resi stance arteries. Regul Pept 105:93–100
Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R, Corti A, Losano G, Cerra MC (2007) Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Am J Physiol Heart Circ Physiol 293(1):H719–H727
Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res Cardiol 101(1):43–52
Cerra MC, Gallo MP, Angelone T, Quintieri AM, Pulerà E, Filice E, Guérold B, Shooshtarizadeh P, Levi R, Ramella R, Brero A, Boero O, Metz-Boutigue MH, Tota B, Alloatti G (2008) The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB J 22(11):3992–4004
Di Felice V, Cappello F, Montalbano A, Ardizzone N, Campanella C, De Luca A, Amelio D, Tota B, Corti A, Zummo G (2006) Human recombinant vasostatin-1 may interfere with cell-extracellular matrix interactions. Ann N Y Acad Sci 1090:305–310
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514–29525
Ferrero E, Scabini S, Magni E, Foglieni C, Belloni D, Colombo B, Curnis F, Villa A, Ferrero ME, Corti A (2004) Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 18:554–556
Filice E, Pasqua T, Quintieri AM, Cantafio P, Scavello F, Amodio N, Cerra MC, Marban C, Schneider F, Metz-Boutigue MH, Angelone T (2015) Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury. Peptides 71:40–48
Fung MM, Salem RM, Mehtani P, Thomas B, Lu CF, Perez B, Rao F, Stridsberg M, Ziegler MG, Mahata SK, O'Connor DT (2010) Direct vasoactive effects of the Chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens 5:278–287
Garofalo F, Parisella ML, Amelio D, Tota B, Imbrogno S (2009) Phospholamban S-nitrosylation modulates Starling response in fish heart. Proc Biol Sci 276(1675):4043–4052
Gasparri A, Sidoli A, Sanchez LP, Longhi R, Siccardi AG, Marchisio PC, Corti A (1997) Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J Biol Chem 272(33):20835–20843
Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M (2008) Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117(21):2761–2768
Hammond J, Balligand JL (2012) Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling. J Mol Cell Cardiol 52:330–340
Han JC, Tran K, Johnston CM, Nielsen PMF, Barrett CJ, Taberner AJ, Loiselle DS (2014) Reduced mechanical efficiency in left ventricular trabeculae of the spontaneously hypertensive rat. Physiol Rep 2:e12211
Hartell NA, Archer HE, Bailey CJ (2005) Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B. Biochem Pharmacol 69(5):781–790
Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14(5):893–907
Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64(22):2863–2886
Hove-Madsen L, Méry PF, Jurevicius J, Skeberdis AV, Fischmeister R (1996) Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91(Suppl 2):1–8. Review
Kim T, Loh YP (2006) Protease nexin-1 promotes secretory granule biogenesis by preventing granule protein degradation. Mol Biol Cell 17(2):789–798
Koshimizu H, Kim T, Cawley NX, Loh YP (2010) Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul Pept 160(1-3):153–159
Koshimizu H, Cawley NX, Kim T, Yergey AL, Loh YP (2011a) Serpinin: a novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells. Mol Endocrinol 25(5):732–744
Koshimizu H, Cawley NX, Yergy AL, Loh YP (2011b) Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death. J Mol Neurosci 45(2):294–303
Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B, Aunis D, Metz-Boutigue MH (2001) Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47–66)-derived peptide. J Biol Chem 276(38):35875–35882
Mahata SK, O’Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autoendocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a non competitive nicotinic cholinergic antagonist. J Clin Invest 100:1623–1633
Mahata SK, Mahata M, Fung MM, O'Connor DT (2010) Catestatin: a multifunctional peptide from chromogranin A. Regul Pept 162(1-3):33–43
Mandalà M, Brekke JF, Serck-Hanssen G, Metz-Boutigue MH, Helle KB (2005) Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery. Regul Pept 124(1-3):73–80
Maniatis NA, Brovkovych V, Allen SE, John TA, Shajahan AN, Tiruppathi C, Vogel SM, Skidgel RA, Malik AB, Minshall RD (2006) Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 99(8):870–877
Matsuda N, Jesmin S, Takahashi Y, Hatta E, Kobayashi M, Matsuyama K, Kawakami N, Sakuma I, Gando S, Fukui H, Hattori Y, Levi R (2004) Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans. J Pharmacol Exp Ther 309(2):786–795
Mattiazzi A, Vittone L, Mundiña-Weilenmann C (2007) Ca2+/calmodulin-dependent protein kinase: a key component in the contractile recovery from acidosis. Cardiovasc Res 73(4):648–656
Mazza R, Pasqua T, Gattuso A (2012) Cardiac heterometric response: the interplay between Catestatin and nitric oxide deciphered by the frog heart. Nitric Oxide 27(1):40–49
Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D (1993) Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217(1):247–257
Metz-Boutigue MH, Goumon Y, Lugardon K, Strub JM, Aunis D (1998) Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol 18(2):249–266
Metz-Boutigue MH, Kieffer AE, Goumon Y, Aunis D (2003) Innate immunity: involvement of new neuropeptides. Trends Microbiol 11(12):585–592
Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefkowitz RJ, Stamler JS (2008) S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 3:395–405
Pasqua T, Corti A, Gentile S, Pochini L, Bianco M, Metz-Boutigue MH, Cerra MC, Tota B, Angelone T (2013) Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts. Endocrinology 154(9):3353–3365
Pasqua T, Tota B, Penna C, Corti A, Cerra MC, Loh YP, Angelone T (2015) pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury. J Endocrinol 227(3):167–178
Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 101(2):168–179
Penna C, Mognetti B, Tullio F, Gattullo D, Mancardi D, Pagliaro P, Alloatti G (2008) The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. J Physiol Pharmacol 59:47–54
Penna C, Alloatti G, Gallo MP, Cerra MC, Levi R, Tullio F, Bassino E, Dolgetta S, Mahata SK, Tota B, Pagliaro P (2010) Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart. Cell Mol Neurobiol 30(8):1171–1179
Perrelli MG, Tullio F, Angotti C, Cerra MC, Angelone T, Tota B, Alloatti G, Penna C, Pagliaro P (2013) Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signaling. Pflugers Arch 465(7):1031–1040
Petroff MG, Kim SH, Pepe S, Dessy C, Marbán E, Balligand JL, Sollott SJ (2010) Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol 3(10):867–873
Pieroni M, Corti A, Tota B, Curnis F, Angelone T, Colombo B, Cerra MC, Bellocci F, Crea F, Maseri A (2007) Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J 28(9):1117–1127
Prendergast BD, Sagach VF, Shah AM (1997) Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96(4):1320–1329
Ramella R, Boero O, Alloatti G, Angelone T, Levi R, Gallo MP (2010) Vasostatin 1 activates eNOS in endothelial cells through a proteoglycan-dependent mechanism. J Cell Biochem 110(1):70–79
Reddy LG, Shi Y, Kutchai H, Filoteo AG, Penniston JT, Thomas DD (1999) An autoinhibitory peptide from the erythrocyte Ca-ATPase aggregates and inhibits both muscle Ca-ATPase isoforms. Biophys J 76(6):3058–3065
Satoh K, Matsu-Ura T, Enomoto M, Nakamura H, Michikawa T, Mikoshiba K (2011) Highly cooperative dependence of sarco/endoplasmic reticulum calcium ATPase(SERCA) 2a pump activity on cytosolic calcium in living cells. J Biol Chem 286:20591–20599
Schmidt AG, Edes I, Kranias EG (2001) Phospholamban: a promising therapeutic target in heart failure? Cardiovasc Drugs Ther 15(5):387–396
Schneider F, Bach C, Chung H, Crippa L, Lavaux T, Bollaert PE, Wolff M, Corti A, Launoy A, Delabranche X, Lavigne T, Meyer N, Garnero P, Metz-Boutigue MH (2012) Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance. Intensive Care Med 38(9):1514–1522
Shaul PW, Afshar S, Gibson LL, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC (2002) Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283(6):L1192–L1199
Stavrakis S, Scherlag BJ, Fan Y, Liu Y, Liu Q, Mao J, Cai H, Lazzara R, Po SS (2012) Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol 23(7):771–777
Tota B, Mazza R, Angelone T, Nullans G, Metz-Boutigue MH, Aunis D, Helle KB (2003) Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart. Regul Pept 114(2–3):123–130
Tota B, Quintieri AM, Di Felice V, Cerra MC (2007) New biological aspects of chromogranin A-derived peptides: focus on vasostatins. Comp Biochem Physiol A Mol Integr Physiol 147(1):11–18
Tota B, Angelone T, Mazza R, Cerra MC (2008) The chromogranin A-derived vasostatins: new players in the endocrine heart. Curr Med Chem 15(14):1444–1451
Tota B, Gentile S, Pasqua T, Bassino E, Koshimizu H, Cawley NX, Cerra MC, Loh YP, Angelone T (2012) The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes. FASEB J 26(7):2888–2898
Tota B, Angelone T, Cerra MC (2014) The surging role of Chromogranin A in cardiovascular homeostasis. Front Chem 2:64
Tsigelny IF, Kouznetsova VL, Biswas N, Mahata SK, O'Connor DT (2013) Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension. Bioorg Med Chem 21(18):5855–5869
Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ (2005) Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther 3(6):1035–1045
Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG (1999) Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ Res 11:1092–1100
Yano N, Ianus V, Zhao TC, Tseng A, Padbury JF, Tseng YT (2007) A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. Am J Physiol Heart Circ Physiol 1:H385–H393
Zhang C (2008) MicroRNAs: role in cardiovascular biology and disease. Clin Sci 114(12):699–706
Zhang YH, Zhang MH, Sears CE, Emanuel K, Redwood C, ElArmouche A, Kranias EG, Casadei B (2008) Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase decient mice. Circ Res 102:242–249
Zhang D, Shooshtarizadeh P, Laventie BJ, Colin DA, Chich JF, Vidic J, de Barry J, Chasserot-Golaz S, Delalande F, Van Dorsselaer A, Schneider F, Helle K, Aunis D, Prévost G, Metz-Boutigue MH (2009) Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS One 4(2):e4501
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Angelone, T., Tota, B., Cerra, M.C. (2017). Cardiac Physio-Pharmacological Aspects of Three Chromogranin A-Derived Peptides: Vasostatin, Catestatin, and Serpinin. In: Angelone, T., Cerra, M., Tota, B. (eds) Chromogranins: from Cell Biology to Physiology and Biomedicine. UNIPA Springer Series. Springer, Cham. https://doi.org/10.1007/978-3-319-58338-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-58338-9_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58337-2
Online ISBN: 978-3-319-58338-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)